Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

VIGABATRIN IMPURITY D CRS (50MG)

VIGABATRIN IMPURITY D CRS (50MG)

56-12-2

DISCOVER
OLMESARTAN MEDOXOMIL CRS (100MG)

OLMESARTAN MEDOXOMIL CRS (100MG)

144689-63-4

DISCOVER
GLUCOSAMINE HYDROCHLORIDE CRS(20 MG)

GLUCOSAMINE HYDROCHLORIDE CRS(20 MG)

66-84-2

DISCOVER
GLUCOSAMINE SULFATE SODIUM CHLORIDE CRS (15 MG)

GLUCOSAMINE SULFATE SODIUM CHLORIDE CRS (15 MG)

38899-05-7

DISCOVER
PRILOCAINE IMPURITY B CRS (80MG)

PRILOCAINE IMPURITY B CRS (80MG)

636-21-5

DISCOVER
TESTOSTERONE PROPIONATE FOR SYSTEM SUITABILITY CRS (10 MG)

TESTOSTERONE PROPIONATE FOR SYSTEM SUITABILITY CRS (10 MG)

57-85-2

DISCOVER
SODIUM FUSIDATE CRS (10 MG)

SODIUM FUSIDATE CRS (10 MG)

751-94-0

DISCOVER
FUSIDIC ACID CRS (15 MG)

FUSIDIC ACID CRS (15 MG)

03/06/6990

DISCOVER
FULVESTRANT FOR SYSTEM SUITABILITY CRS (15 MG)

FULVESTRANT FOR SYSTEM SUITABILITY CRS (15 MG)

129453-61-8

DISCOVER
HUMAN HEPATITIS B IMMUNOGLOBULIN BRP (100 MG)

HUMAN HEPATITIS B IMMUNOGLOBULIN BRP (100 MG)

NA

DISCOVER
DIPHENOXYLATE HYDROCHLORIDE CRS - * NARC (15 MG)

DIPHENOXYLATE HYDROCHLORIDE CRS - * NARC (15 MG)

3810-80-8

DISCOVER
BETAMETHASONE DIPROPIONATE FOR PEAK IDENTIFICATION CRS (10 M

BETAMETHASONE DIPROPIONATE FOR PEAK IDENTIFICATION CRS (10 M

5593-20-4

DISCOVER